Login / Signup

Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19.

Weilong ZhangYinghua LvJuan YangYunhui ChenYingchun HeJihan Huang
Published in: Drug design, development and therapy (2020)
The design characteristics of clinical trials of antiviral drugs for treating COVID-19 as well as the mechanism of action and antiviral efficacy of the drugs were evaluated in this study. The results of these trials could constitute a reference for future clinical trials to be executed on COVID-19 treatment and prevention.
Keyphrases
  • clinical trial
  • coronavirus disease
  • sars cov
  • phase ii
  • open label
  • double blind
  • phase iii
  • study protocol
  • respiratory syndrome coronavirus
  • high throughput
  • randomized controlled trial
  • drug induced
  • single cell